JMP Securities Downgrades Minerva Neurosciences to Market Perform

JMP Securities analyst Jason Butler downgrades Minerva Neurosciences (NASDAQ:NERV) from Market Outperform to Market Perform.

JMP Securities analyst Jason Butler downgrades Minerva Neurosciences (NASDAQ:NERV) from Market Outperform to Market Perform.

Total
0
Shares
Related Posts
Read More

‘Paxlovid, Nirmatrelvir 150mg And Ritonavir 100mg, Film-Coated Tablets Expiry Date Extended Beyond The Labelled Expiry Date On The Pack; Approved By The Medicines And Healthcare Products Regulatory Agency’ – U.K Government

https://www.gov.uk/government/publications/expiry-date-of-paxlovid-nirmatrelvir-and-ritonavir-antiviral-medication-extended/paxlovid-nirmatrelvir-150mg-and-ritonavir-100mg-film-coated-tablets-expiry-date-extended’ Paxlovid (nirmatrelvir 150mg and ritonavir 100mg) film-coated tablets expiry date extended Published 21 December 2022 This guidance…

PFE